Search results
New era for pot regulation leaves old problem: Many cannabis companies can’t find a bank
The Journal Times· 1 day agoThe Biden administration's move to reclassify marijuana as a less dangerous but still controlled...
Four Jacobs School Faculty Members Named SUNY Distinguished Professors
UB Reporter· 3 days agoFour Jacobs School of Medicine and Biomedical Sciences faculty members have been named SUNY Distinguished Professors, the highest faculty rank in the SUNY system. The rank of distinguished professor ...
Survey: High-THC Flower Yields Few Serious Side Effects in Patients
High Times· 3 days ago“Patients were allowed to participate only if they received a cannabis-based treatment from pharmacies in the form of cannabis flowers prescribed by a physician,” the < ...
FY2025 EPS Estimates for TG Therapeutics, Inc. (NASDAQ:TGTX) Lowered by B. Riley
ETF DAILY NEWS· 20 hours agoTG Therapeutics, Inc. (NASDAQ:TGTX – Free Report) – Equities researchers at B. Riley cut their FY2025 earnings estimates for shares of TG Therapeutics in a research ...
A year out from legal medical marijuana, legislature makes final updates - The Advocate-Messenger
The Danville Advocate-Messenger· 4 days agoKentucky is a year closer to legalized medical marijuana, and the state legislature is making its...
FSD Pharma Signs Agreement with Applied Science and Performance Institute (ASPI) to Conduct a...
The Joplin Globe· 5 days ago(NASDAQ:HUGE)(CSE:HUGE)(FRA:0K9A) ("FSD Pharma" of the "Company"), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions for the treatment ...
New era for pot regulation leaves old problem: Many cannabis companies can’t find a bank
The Chippewa Herald· 1 day agoThe Biden administration's move to reclassify marijuana as a less dangerous but still controlled...
Alkermes' (ALKS) Q1 Earnings & Revenues Fall Shy of Estimates
Zacks· 4 days agoFree Report) reported adjusted earnings from continuing operations of 44 cents per share for first-quarter 2024, which missed the Zacks Consensus Estimate of 59 cents. ALKS’ revenues of $350.4 ...
NeuroSense Announces First Quarter 2024 Business Update
WRBL Columbus· 3 days agoNeuroSense Therapeutics Ltd. (Nasdaq: NRSN) ("NeuroSense"), a company developing novel treatments for severe neurodegenerative diseases, today provides a business update.